ATUM (Biotechnology) Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
129
- Latest Deal Type
-
2ndary - Private
ATUM (Biotechnology) General Information
Description
Developer of an integrated biologics development platform designed to streamline the end-to-end process from virtual sequence to research cell bank. The company's platform combines machine learning, gene synthesis, protein expression, and cell line development capabilities, enabling biopharma companies to accelerate antibody and biologics CMC workflows.
Contact Information
Website
www.atum.bioCorporate Office
- 37950 Central Court
- Newark, CA 94560
- United States
Corporate Office
- 37950 Central Court
- Newark, CA 94560
- United States
ATUM (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Later Stage VC | Completed | Generating Revenue | ||||
| 5. Grant | 23-Feb-2011 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2008 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2007 | Completed | Generating Revenue | |||
| 2. Grant | 11-Dec-2006 | Completed | Generating Revenue | |||
| 1. Grant | 01-Jan-2006 | $974K | Completed | Generating Revenue |
ATUM (Biotechnology) Comparisons
Industry
Financing
Details
ATUM (Biotechnology) Competitors (22)
One of ATUM (Biotechnology)’s 22 competitors is Adaptyv, a Venture Capital-Backed company based in Lausanne, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Adaptyv | Venture Capital-Backed | Lausanne, Switzerland | ||||
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| Mayflower Bioscience | Formerly Accelerator/Incubator backed | Saint Louis, MO | ||||
| Novus Biologicals | Formerly PE-Backed | Centennial, CO | ||||
| BioLegend | Formerly Accelerator/Incubator backed | San Diego, CA |
ATUM (Biotechnology) Signals
ATUM (Biotechnology) Investments & Acquisitions (3)
ATUM (Biotechnology)’s most recent deal was a Early Stage VC with Wheeler Bio for . The deal was made on 18-May-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Wheeler Bio | 18-May-2023 | Early Stage VC | Biotechnology | ||
| ZymoChem | 09-Sep-2021 | Later Stage VC | Biotechnology | ||
| MIGS | 26-Apr-2016 | Merger/Acquisition | Biotechnology |
ATUM (Biotechnology) FAQs
-
When was ATUM (Biotechnology) founded?
ATUM (Biotechnology) was founded in 2003.
-
Where is ATUM (Biotechnology) headquartered?
ATUM (Biotechnology) is headquartered in Newark, CA.
-
What is the size of ATUM (Biotechnology)?
ATUM (Biotechnology) has 129 total employees.
-
What industry is ATUM (Biotechnology) in?
ATUM (Biotechnology)’s primary industry is Discovery Tools (Healthcare).
-
Is ATUM (Biotechnology) a private or public company?
ATUM (Biotechnology) is a Private company.
-
What is ATUM (Biotechnology)’s current revenue?
The current revenue for ATUM (Biotechnology) is .
-
Who are ATUM (Biotechnology)’s competitors?
Adaptyv, Abcam, Mayflower Bioscience, Novus Biologicals, and BioLegend are some of the 22 competitors of ATUM (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process